日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy.

PTK7靶向放射性核素疗法的临床前评价

Lindland Kim, Westrøm Sara, Dragovic Srdan M, Li Ruth Gong, Malenge Marion Masitsa, Ho Betty, Juzeniene Asta, Bønsdorff Tina Bjørnlund

Antigen targeting and anti-tumor activity of a novel anti-CD146 (212)Pb internalizing alpha-radioimmunoconjugate against malignant peritoneal mesothelioma.

新型抗CD146(212)Pb内化α放射免疫缀合物对恶性腹膜间皮瘤的抗原靶向性和抗肿瘤活性

Lindland Kim, Malenge Marion Masitsa, Li Ruth Gong, Wouters Roxanne, Bønsdorff Tina Bjørnlund, Juzeniene Asta, Dragovic Srdan M

An Experimental Generator for Production of High-Purity (212)Pb for Use in Radiopharmaceuticals

用于生产放射性药物用高纯度(212)Pb的实验性发生器

Li, Ruth Gong; Stenberg, Vilde Yuli; Larsen, Roy Hartvig

Improved Formulation of (224)Ra-Labeled Calcium Carbonate Microparticles by Surface Layer Encapsulation and Addition of EDTMP

通过表面层包封和添加EDTMP改进(224)Ra标记碳酸钙微粒的配方

Li, Ruth Gong; Lindland, Kim; Tonstad, Sandra Karen; Bønsdorff, Tina Bjørnlund; Juzeniene, Asta; Westrøm, Sara; Larsen, Roy Hartvig

A Novel Single-Step-Labeled (212)Pb-CaCO(3) Microparticle for Internal Alpha Therapy: Preparation, Stability, and Preclinical Data from Mice

一种新型单步标记的(212)Pb-CaCO(3)微粒用于体内α疗法:制备、稳定性及小鼠临床前数据

Li, Ruth Gong; Lindland, Kim; Bønsdorff, Tina Bjørnlund; Westrøm, Sara; Larsen, Roy Hartvig